<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Solana Company — News on 6ix</title>
    <link>https://6ix.com/company/helius-medical-technologies-inc-class-a</link>
    <description>Latest news and press releases for Solana Company on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 15 May 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/helius-medical-technologies-inc-class-a" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68357fa278dffbe2df0fb1c3.webp</url>
      <title>Solana Company</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a</link>
    </image>
    <item>
      <title>Solana Company Reports First Quarter 2026 Financial Results</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-reports-first-quarter-2026-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-reports-first-quarter-2026-financial-results</guid>
      <pubDate>Fri, 15 May 2026 04:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., May 15, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company, today announced results for</description>
    </item>
    <item>
      <title>Solana Company to Release First Quarter 2026 Operating Results on May 15, 2026</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-to-release-first-quarter-2026-operating-results-on-may-15-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-to-release-first-quarter-2026-operating-results-on-may-15-2026</guid>
      <pubDate>Mon, 11 May 2026 04:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company, today announced that the</description>
    </item>
    <item>
      <title>Jito Foundation and Solana Company (NASDAQ: HSDT) Announce Strategic Partnership to Expand Institutional Solana Infrastructure Across Asia-Pacific Region</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/jito-foundation-and-solana-company-nasdaq-hsdt-announce-strategic-partnership-to-expand-institutional-solana-infrastructure-across-asia-pacific-region</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/jito-foundation-and-solana-company-nasdaq-hsdt-announce-strategic-partnership-to-expand-institutional-solana-infrastructure-across-asia-pacific-region</guid>
      <pubDate>Wed, 06 May 2026 13:00:00 GMT</pubDate>
      <description>Pairing Jito&apos;s market layer technology and Solana Company&apos;s institutional Pacific Backbone platform intended to advance validator infrastructure and staking solutions across Asia-PacificMIAMI, May 06, 2026 (GLOBE NEWSWIRE) -- Jito Foundation, the organization supporting the development of the Jito ecosystem and the team behind the execution infrastructure underpinning the Solana network, today announced a strategic partnership with Solana Company (NASDAQ: HSDT), a leading institutional blockchai</description>
    </item>
    <item>
      <title>Solana Company (NASDAQ: HSDT) Announces Registered Direct Offering of Common Stock to Global Institutional Investor</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-nasdaq-hsdt-announces-registered-direct-offering-of-common-stock-to-global-institutional-investor</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-nasdaq-hsdt-announces-registered-direct-offering-of-common-stock-to-global-institutional-investor</guid>
      <pubDate>Mon, 27 Apr 2026 04:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., April 27, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (“HSDT” or the “Company”), a publicly listed company that has expanded its</description>
    </item>
    <item>
      <title>Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-nasdaq-hsdt-appoints-madelene-gani-as-chief-operating-officer-and-deputy-cfo-to-lead-next-phase-of-growth</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-nasdaq-hsdt-appoints-madelene-gani-as-chief-operating-officer-and-deputy-cfo-to-lead-next-phase-of-growth</guid>
      <pubDate>Thu, 09 Apr 2026 04:00:00 GMT</pubDate>
      <description>A veteran architect of Gemini’s Asia Pacific expansion, Ms. Gani joins to lead institutional buildout as Solana Company executes on its strategy to drive</description>
    </item>
    <item>
      <title>Solana Company Reports Fourth Quarter and Full Year 2025 Financial Results</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-reports-fourth-quarter-and-full-year-2025-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
      <pubDate>Mon, 30 Mar 2026 04:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., March 30, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its</description>
    </item>
    <item>
      <title>Solana Company to Release Fourth Quarter and Full Year 2025 Operating Results on March 30, 2026</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-to-release-fourth-quarter-and-full-year-2025-operating-results-on-march-30-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-to-release-fourth-quarter-and-full-year-2025-operating-results-on-march-30-2026</guid>
      <pubDate>Tue, 24 Mar 2026 20:05:00 GMT</pubDate>
      <description>NEWTOWN, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to acquiring and holding Solana (SOL), today announced that the Company will release its fourth quarter and full year operating results on Monday, March 30, 2026, after market close. Management will host a conference call to discuss the results and provide an expanded business update as fol</description>
    </item>
    <item>
      <title>Solana Company (NASDAQ: HSDT) Announces Plan for the Pacific Backbone, a High-Speed Infrastructure Buildout for Solana</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-nasdaq-hsdt-announces-plan-for-the-pacific-backbone-a-high-speed-infrastructure-buildout-for-solana</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-nasdaq-hsdt-announces-plan-for-the-pacific-backbone-a-high-speed-infrastructure-buildout-for-solana</guid>
      <pubDate>Mon, 23 Feb 2026 05:00:00 GMT</pubDate>
      <description>Deployment to be focused on Asia-Pacific region to capitalize on fast-growing wealth accumulation, cross-border payments, and institutional adoption of</description>
    </item>
    <item>
      <title>Solana Company Reports Third Quarter 2025 Financial Results</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-reports-third-quarter-2025-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-reports-third-quarter-2025-financial-results</guid>
      <pubDate>Tue, 18 Nov 2025 21:05:00 GMT</pubDate>
      <description>NEWTOWN, Pa., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury (“DAT”) dedicated to acquiring and holding Solana tokens (“SOL”), today announced results for the quarter ended September 30, 2025. Third Quarter and Recent Business Updates Closed partnership with Pantera Capital and Summer Capital of over $500 Million in funding in cash and stablecoins to launch SOL</description>
    </item>
    <item>
      <title>Solana Company to Release Third Quarter Operating Results on November 18, 2025</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-release-third-quarter-operating-results-november-18-2025-2025-11-12</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-release-third-quarter-operating-results-november-18-2025-2025-11-12</guid>
      <pubDate>Wed, 12 Nov 2025 05:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its</description>
    </item>
    <item>
      <title>Solana Company (NASDAQ: HSDT) Releases Investor Update</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-nasdaq-hsdt-releases-investor-update</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-nasdaq-hsdt-releases-investor-update</guid>
      <pubDate>Wed, 05 Nov 2025 14:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to acquiring and holding Solana (SOL), today announced that its Board of Directors has approved a stock repurchase program to acquire up to $100 million of the company&apos;s outstanding common stock. The new stock repurchase program, which is open-ended, allows the company to repurchase its shar</description>
    </item>
    <item>
      <title>Solana Company Files Application to Cease to Be a Reporting Issuer in Canada</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-files-application-cease-be-reporting-issuer-canada-2025-11-04</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/solana-company-files-application-cease-be-reporting-issuer-canada-2025-11-04</guid>
      <pubDate>Tue, 04 Nov 2025 05:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (“Solana” or the “Company”) today announced that it has applied to the British</description>
    </item>
    <item>
      <title>CORRECTION – Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/correction-solana-company-announces-updated-sol-holdings-and-industry-leading-staking-yield</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/correction-solana-company-announces-updated-sol-holdings-and-industry-leading-staking-yield</guid>
      <pubDate>Wed, 29 Oct 2025 04:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Wednesday, October 29th by Solana Company (NASDAQ: HSDT),</description>
    </item>
    <item>
      <title>Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-announces-fda-510k-submission-ponsr-device-label-expansion-stroke-2025-09-25</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-announces-fda-510k-submission-ponsr-device-label-expansion-stroke-2025-09-25</guid>
      <pubDate>Thu, 25 Sep 2025 04:00:00 GMT</pubDate>
      <description>Seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under its Breakthrough Device Designation NEWTOWN, Pa., Sept.</description>
    </item>
    <item>
      <title>Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Closes Over $500 Million Private Placement to Launch SOL Treasury Company</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-nasdaqhsdt-in-partnership-with-pantera-capital-and-summer-capital-closes-over-dollar500-million-private-placement-to-launch-sol-treasury-company</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-nasdaqhsdt-in-partnership-with-pantera-capital-and-summer-capital-closes-over-dollar500-million-private-placement-to-launch-sol-treasury-company</guid>
      <pubDate>Thu, 18 Sep 2025 04:00:00 GMT</pubDate>
      <description>Preeminent SOL-backed treasury vehicle - with potential to raise over $1.25 billion aggregate gross proceeds - unlocks capital markets to accelerate Solana&apos;s</description>
    </item>
    <item>
      <title>Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-nasdaqhsdt-in-partnership-with-pantera-capital-and-summer-capital-announces-over-dollar500-million-in-funding-to-launch-sol-treasury-company</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-nasdaqhsdt-in-partnership-with-pantera-capital-and-summer-capital-announces-over-dollar500-million-in-funding-to-launch-sol-treasury-company</guid>
      <pubDate>Mon, 15 Sep 2025 04:00:00 GMT</pubDate>
      <description>Preeminent SOL-backed treasury vehicle - with potential to deliver over $1.25 billion - unlocks capital markets to accelerate Solana&apos;s growth The offering</description>
    </item>
    <item>
      <title>Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-announces-positive-outcome-portable-neuromodulation-stimulator-ponsr-stroke</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-announces-positive-outcome-portable-neuromodulation-stimulator-ponsr-stroke</guid>
      <pubDate>Mon, 21 Jul 2025 04:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel</description>
    </item>
    <item>
      <title>Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-medical-technologies-inc-compliant-nasdaqs-continued-listing-requirements-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-medical-technologies-inc-compliant-nasdaqs-continued-listing-requirements-2025</guid>
      <pubDate>Wed, 09 Jul 2025 04:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on</description>
    </item>
    <item>
      <title>Helius Medical Technologies Announces Reverse Stock Split</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-medical-technologies-announces-reverse-stock-split-2025-06-27</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-medical-technologies-announces-reverse-stock-split-2025-06-27</guid>
      <pubDate>Fri, 27 Jun 2025 04:00:00 GMT</pubDate>
      <description>NEWTOWN, Pa., June 27, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on</description>
    </item>
    <item>
      <title>Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device</title>
      <link>https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-medical-technologies-inc-announces-claim-authorization-cignahealth-its</link>
      <guid isPermaLink="true">https://6ix.com/company/helius-medical-technologies-inc-class-a/news/helius-medical-technologies-inc-announces-claim-authorization-cignahealth-its</guid>
      <pubDate>Mon, 16 Jun 2025 04:00:00 GMT</pubDate>
      <description>- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another</description>
    </item>
  </channel>
</rss>